GOLGA7, acting as a communal partner within the RAS‐PAT complex, has been reported to serve as a stabilizer for members of the ZDHHC9 PAT subfamily by binding with the conserved PATs’ C‐terminal cysteine motif in vitro.[28, 29, 30] Despite being a noncatalytic component in the complex, GOLGA7 was recently found to play key roles in regulating NRAS trafficking to the PM and subsequent oncogenic signaling in leukemia cells.[31, 32] However, its role in suppressing leukemogenesis in vivo remains uncertain. Here, ZDHHC9 is linked to leukemia.